GILD - The Sleeping Giant - Trend ReversalGILD - The Sleeping Giant - Trend Reversal
___________________
ENTRY = 56.56 Double Bottom - +64 confirmation
1st Target = .236fib@72.33
2nd Target = .382fib@82.08
3rd Target = .5fib@89.97
HOLD Target = .618@97.85+
JAN22 Call Leaps Still cheap
________________________________________________________________________________________________________________________
This content is for informational and educational purposes only. This is not in any way, shape or form financial or trading advice.
Good luck, happy trading and stay chill,
2degreez
Trade ideas
GILD double bottom on daily, Broke Down Trend, New HEPB Trials $Gild on 1/12 announced a partnership for a phase 2 trial on a new HEP B cure. It also got an upgrade on Jan 4th and it's covid treatment usage is going up due to rising covid numbers. Waiting for trigger of close above .618 fib for a weekly swing on this ticker. Overall Gild looks promising long term.
BUY $GILD - NR Picks Dec 06EN: Gilead Sciences, Inc. is an American biopharmaceutical company based in Foster City, California, that researches, develops and markets drugs in under-explored areas of medical need in the United States, Europe, and
internationally. Its products include treatments for human immunodeficiency virus (HIV) infection and liver disease.
It is currently at a key level of the last three months that could indicate a change in trend, being able to surpass its resistance of 61 - 62 and would reach the sell zone.
It should be mentioned that in recent years its dividend has increased from 2% in 2015 to 4% in 2020. December 14 is its cutoff date and it is scheduled to pay dividends on December 30.
In terms of its income structure, products related to HIV treatment represent 70% of its income, its main market being the United States.
ES: Gilead Sciences, Inc. es una compañía biofarmacéutica estadounidense con sede en Foster City, California, que investiga, desarrolla y comercializa medicamentos en áreas de necesidades médicas poco exploradas en los
Estados Unidos, Europa e internacionalmente. Sus productos incluyen tratamientos contra la infección por el virus de la inmunodeficiencia humana (VIH) y enfermedades hepáticas.
Actualmente se encuentra en un nivel clave de los últimos tres meses que podría indicar un cambio de tendencia, pudiendo sobrepasar su resistencia de los 61 – 62 y alcanzaría la zona de venta.
Cade mencionar que en los últimos años ha ido incrementado su dividendo pasando de 2% en el 2015 a un 4% en el 2020. El 14 de Diciembre es su fecha de corte y tiene programado pagar dividendos el 30 de Diciembre.
En cuanto a su estructura de ingresos los productos relacionados al tratamiento del VIH representan un 70% de sus ingresos siendo su mercado principal Estados Unidos.
GILD: will it finally break the curse?GILD seems to be finally attempting to make a serious up move and breaking back into the $60's
we've been holding this long position for a while, and was about to declare it a loser and close on a loss (which i totally hate!!), given the many signs of weakness GILD showed (yellow arrows), even when there was reasons to show strength (Remdesivir used on POTUS, strong market days, positive earnings ...etc) - if you have been watching GILD in the past few weeks, i'm sure you can remember these events.
it was as if the market is working against GILD - every time there was some strength, sellers will just pile on it and bring the price down again! GILD went all the way down to the 2013 price levels.
What changed?
now for the first time we see some *positive momentum* coupled with bullish sentiment that has been up for 2 whole weeks (marked with yellow circle on the UTO on the daily) - then a relatively successful attempt today to break the down trend (been on since May) and break out from what seems to be a bottom formation
What's next?
for confirmation of a reversal to the upside, we need to see a close above $62, and the bulls to defend that range with commitment (price doesn't go back below $60) and drive the price up into the safe zone -- and maybe get some uptrend ?-- for me this is the last chance holding a loser - so i'm watching closely.
Let me know your views.






















